Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Endocrine System Diseases × Chorionic Gonadotropin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Uterine Anomalies 1 Salpingitis 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Leiomyoma 1 Infertility, Female 1 Infertility 1 Gonadal Disorders 1 Endometritis 1 Endometriosis 1 Endocrine System Diseases 1

Interventions

selpercatinib 2 repotrectinib 1 pralsetinib 1 Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00947713 2011-07-15

Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome

Royan Institute

Phase 1/2 Completed

Endocrine System Diseases, Gonadal Disorders, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡